Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Stem Cell Therapy
Spinal Stem Cells 'Lure' Tumours to the Spine, Study Shows
An animal model study suggests that cells produced by breast cancer preferentially metastasize to the spine over other bones in the body, with key proteins identified as affecting spinal tropism.
Tumour Microenvironment
Positive Phase I Data from Oncolytic Virotherapy Trial
TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.
Antibody & Protein Engineering
Post-Event Proceedings - Biologics 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023
Drug Discovery & Development
Bispecific Antibody Format: Interview with Laura von Schantz, Chief Technology Officer, Alligator Biosciences
Talking with Laura von Schantz, Chief Technology Officer, at Alligator Biosciences about their RUBY bispecific antibody format.
Immuno-Oncology
10x Genomics: Inside Visium Spatial Capture Technology
Visium Spatial Gene Expression incorporates whole transcriptome analysis for intact tissues sections with morphological context. Bringing these complementary methods together offers a previously inaccessible view of tissue biology.
Biomarkers & Precision Medicine
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
Biomarkers & Precision Medicine
Bioanalytical Solutions for CAR-T and NK Cell Therapies
Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery